Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Inotrem reports positive data from Phase IIa trial of nangibotide

The Phase IIa trial on septic shock included patients in Belgium, France, The Netherlands and Spain. Credit: Inotrem.



Go Top